Concussion, Brain Completed Phase 1 Trials for Ondansetron (DB00904)

Also known as: Brain Concussion

IndicationStatusPhase
DBCOND0068147 (Concussion, Brain)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01815125Ondansetron for Pediatric Mild Traumatic Brain InjuryTreatment